Mesenchymal stem cell secretome alleviates dry eye disease and attenuates DLK-associated MAPK and necroptosis signaling- related inflammation
Year: 2026
Type: article
Abstract: Mesenchymal stem cell secretome (MSC-S) has shown therapeutic potential for several inflammatory diseases, and dry eye disease (DED) is a prevalent chronic inflammatory ocular surface disease. Therefore, in this study, we investigated the therapeutic effects of MSC-S on DED and elucidated the underlying molecular mechanisms. A murine DED model was established and treated with 10 mg/mL MSC-S. Tear secretion and corneal fluorescein staining scores were obtained to evaluate the severity of DED and corneal epithelial damage, respectively. We detected ocular surface inflammation using flow cytometry of dendritic cells and reverse transcription-polymerase chain reaction analysis of inflammatory factors. The human corneal epithelial cell line (HCECs) was subjected to hyperosmotic stress (HS, 500 mOsM). Cell proliferation, reactive oxygen species production, and mitochondrial levels were assessed. Corneal RNA sequencing and pathway validation were performed to elucidate the mechanisms underlying MSC-S treatment. The overexpression and knockout of dual leucine zipper kinase (DLK) were used to determine the functional contribution of DLK in HS-induced HCEC injury. Proteomic profiling, enrichment analysis, and protein–protein interaction network analysis were performed to characterize MSC-S and prioritize candidate bioactive components. MSC-S improved tear secretion and reduced corneal defects and inflammation in DED mice. Furthermore, it protected HCECs from necroptosis in the HS model. RNA sequencing and pathway analyses identified coordinated alterations in mitogen-activated protein kinase (MAPK) signaling and necroptosis-related genes in DED corneas that were attenuated after MSC-S treatment. Dysregulated MAPK-related genes prioritize DLK. In HCECs, DLK overexpression exacerbated DED and impaired MSC-S therapy effects, accompanied by upregulation of the Janus kinase and p38 MAPK pathways, the necroptosis pathway, and inflammatory factors. MSC-S proteomics identified 417 proteins and revealed the enrichment of proteins associated with MAPK signaling, immune responses, inflammation, and apoptosis regulation. PPI analysis revealed SERPINE1 as a candidate MSC-S component, with a predicted network association with DLK. This study demonstrates that MSC-S can inhibit the DLK-mediated MAPK signaling and necroptosis-associated response. Proteomic analysis identified SERPINE1 and other candidate MSC-S components for future functional investigations. These findings may provide an effective strategy for treating DED and propose new therapeutic targets. Not applicable.
Language: English
Subfield: Ophthalmology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,890
Awards: G1283546427, G9001400486
OpenAlex ID: W7236998880
